The Joint Committee on Vaccination and Immunisation’s Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?

Value in Health
November 2019 Volume 22, Issue 11, p1227-1344
https://www.valueinhealthjournal.com/issue/S1098-3015(19)X0011-X

 

COMMENTARY
The Joint Committee on Vaccination and Immunisation’s Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?
James F. O’Mahony, Mike Paulden
p1227–1230
Published online: September 6, 2019